The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
Clear business PR as the sources are not satisfying our policies about companies and what they contain,
this search emphasizes there's then nothing but PR and what they've said themselves in their own publishings; none of this is inherited any automatic notability simply because of the stock exchange or the fact they have a few million in income, because WP:NOT has a higher place in this and it allows removal of anything used as a business webhost.
SwisterTwistertalk18:11, 10 January 2017 (UTC)reply
Keep This is a company listed on the New York Stock Exchange with more than $400 million in revenue in a key area in the pharmaceutical field. The claim of "corporate spam" is patently false and if there is anything that constitutes "spam", the proper solution is editing, not deletion. There are ample sources about the company available in a Google search using Cambrex or its ticker symbol CBM as a search term.
Alansohn (
talk)
05:35, 18 January 2017 (UTC)reply
Keep. As a quick news search will readily show, there are hundreds of recent articles in reliable independent sources about this company's business activities. The article in its current state certainly needs those independent sources added to it, but the tone and content don't strike me as promotional. Problems with this article should be dealt with through editing, not through deletion.
Gnome de plume (
talk)
20:22, 18 January 2017 (UTC)reply
Comment - So currently all we have for substance is the NYSE, but our policies specifically need good substantial coverage, in which I'm only finding trivial business announcements, press releases and all.
SwisterTwistertalk00:16, 19 January 2017 (UTC)reply
Comment -- by "corporate spam" I mean this:
In 2007, the firm decided to focus on its core competencies... (promo content)
Steve Klosk was appointed CEO, while remaining President... (non notable CEO)
To broaden their biocatalysis platform... (promo language)
In 2014, they acquired Zenara Pharma to enhance its drug product formulation capabilities... (promo language)
Each sentence is basically promotion. This content belongs on the company web site, not in an encyclopedia. No sources have been presented at this AfD that provide independent, reliable coverage.
WP:LISTED is not a pass to a "free article" absent sources and with a clear violation of
WP:PROMO.
K.e.coffman (
talk)
06:53, 20 January 2017 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
Clear business PR as the sources are not satisfying our policies about companies and what they contain,
this search emphasizes there's then nothing but PR and what they've said themselves in their own publishings; none of this is inherited any automatic notability simply because of the stock exchange or the fact they have a few million in income, because WP:NOT has a higher place in this and it allows removal of anything used as a business webhost.
SwisterTwistertalk18:11, 10 January 2017 (UTC)reply
Keep This is a company listed on the New York Stock Exchange with more than $400 million in revenue in a key area in the pharmaceutical field. The claim of "corporate spam" is patently false and if there is anything that constitutes "spam", the proper solution is editing, not deletion. There are ample sources about the company available in a Google search using Cambrex or its ticker symbol CBM as a search term.
Alansohn (
talk)
05:35, 18 January 2017 (UTC)reply
Keep. As a quick news search will readily show, there are hundreds of recent articles in reliable independent sources about this company's business activities. The article in its current state certainly needs those independent sources added to it, but the tone and content don't strike me as promotional. Problems with this article should be dealt with through editing, not through deletion.
Gnome de plume (
talk)
20:22, 18 January 2017 (UTC)reply
Comment - So currently all we have for substance is the NYSE, but our policies specifically need good substantial coverage, in which I'm only finding trivial business announcements, press releases and all.
SwisterTwistertalk00:16, 19 January 2017 (UTC)reply
Comment -- by "corporate spam" I mean this:
In 2007, the firm decided to focus on its core competencies... (promo content)
Steve Klosk was appointed CEO, while remaining President... (non notable CEO)
To broaden their biocatalysis platform... (promo language)
In 2014, they acquired Zenara Pharma to enhance its drug product formulation capabilities... (promo language)
Each sentence is basically promotion. This content belongs on the company web site, not in an encyclopedia. No sources have been presented at this AfD that provide independent, reliable coverage.
WP:LISTED is not a pass to a "free article" absent sources and with a clear violation of
WP:PROMO.
K.e.coffman (
talk)
06:53, 20 January 2017 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.